pharma · Epilepsy · Allergic Reaction · AQST
Aquestive Therapeutics
Aquestive Therapeutics patent portfolio — 17 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Vancouver, CA
- Founded
- 2009
- Employees
- 75
- Programs
- 9
- Drugs
- 9
- Patents
- 17
Aquestive Therapeutics patents
17 pharmaceutical patents indexed for Aquestive Therapeutics. 0 expire within 24 months.
Aquestive Therapeutics has 17 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12427121
Enhanced delivery epinephrine compositions
granted -
US 12403090
Oral film compositions and dosage forms having precise active dissolution profiles
granted -
US 12290597
Oral film compositions and dosage forms having precise active dissolution profiles
granted -
US 12023309
Enhanced delivery epinephrine compositions
granted -
US 11541002
Oral film compositions and dosage forms having precise active dissolution profiles
granted -
US 11273131
Pharmaceutical compositions with enhanced permeation
granted -
US 11191737
Enhanced delivery epinephrine compositions
granted -
US 11129799
Dual lane coating
granted -
US 11077068
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
granted -
US 10947033
Reduction in stress cracking of films
granted -
US 10940626
Manufacturing of small film strips
granted -
US 10888499
Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
granted -
US 10821074
Sublingual and buccal film compositions
granted -
US 10464739
Reduction in stress cracking of films
granted -
US 10272607
Manufacturing of small film strips
granted -
US 10111810
Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
granted -
US 10034833
Sublingual and buccal film compositions
granted
Frequently asked questions
How many patents does Aquestive Therapeutics have?
17 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Aquestive Therapeutics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.